UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by AIA Group Ltd

AIA Group Ltd trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 26.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 15,780 shares of the healthcare conglomerate’s stock after selling 5,601 shares during the period. AIA Group Ltd’s holdings in UnitedHealth Group were worth $7,806,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Motive Wealth Advisors raised its holdings in shares of UnitedHealth Group by 50.8% in the 1st quarter. Motive Wealth Advisors now owns 665 shares of the healthcare conglomerate’s stock worth $329,000 after purchasing an additional 224 shares during the period. Houlihan Financial Resource Group Ltd. purchased a new position in shares of UnitedHealth Group in the 1st quarter worth about $259,000. Stokes Family Office LLC raised its holdings in shares of UnitedHealth Group by 27.2% during the 1st quarter. Stokes Family Office LLC now owns 3,421 shares of the healthcare conglomerate’s stock valued at $1,692,000 after buying an additional 731 shares during the period. Quantbot Technologies LP purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $12,760,000. Finally, Envestnet Portfolio Solutions Inc. raised its holdings in shares of UnitedHealth Group by 12.5% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 110,338 shares of the healthcare conglomerate’s stock valued at $54,584,000 after buying an additional 12,260 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $7.17 during midday trading on Friday, reaching $511.53. 3,532,475 shares of the company traded hands, compared to its average volume of 4,236,860. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The firm has a market capitalization of $470.81 billion, a price-to-earnings ratio of 31.27, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The company has a fifty day moving average price of $499.58 and a 200 day moving average price of $499.99.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.26 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a yield of 1.64%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is presently 51.34%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several analyst reports. Truist Financial reiterated a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective on the stock in a report on Wednesday, June 5th. TD Cowen dropped their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Finally, Wells Fargo & Company dropped their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $581.44.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.